Shanghai, China

Taichang Yuan

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taichang Yuan. Retrieved from https://idiyas.com/inventor/taichang-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taichang Yuan: Innovator in Cancer Treatment

Introduction

Taichang Yuan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.

Latest Patents

Yuan holds a patent for "Phenyl-pyridine/pyrazine amides for the treatment of cancer." This invention provides novel compounds that have the potential to improve therapeutic outcomes for cancer patients. His work in this area is crucial for advancing medical treatments.

Career Highlights

Taichang Yuan is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Yuan has worked alongside talented colleagues, including Hui Hu and Min Jiang. Their combined expertise enhances the research efforts and fosters innovation in cancer treatment.

Conclusion

Taichang Yuan's contributions to cancer treatment through his patent and work at Hoffmann-La Roche Inc. highlight his dedication to improving healthcare. His innovative spirit and collaboration with other experts continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…